Trestle Biotherapeutics
ActiveBioengineered kidneys for patients with kidney failure
What it does
We are developing an implantable therapeutic tissue that will be surgically delivered to patients suffering from end stage renal disease. Upon implantation, this tissue will supplement the patient's renal function, eliminating their dependency on dialysis and improving their disease status. This has the potential to not only get these patients off dialysis - a significant impact for them and their families - but to greatly extend the time required before kidney transplantation is essential.
Its site says now · captured 2026-08-23
Trestle Biotherapeutics | Bioengineered therapies for Kidney isease.
Bioengineered Therapies
Next to it in Healthcare and bio · Bioengineered kidney tissue for ESRD
- VolumetricY Combinator W20
Volumetric builds living multicellular tissues with a focus on the…
- BrinterPlug and Play PnP 2024
Brinter platform develops the first-ever 3D bioprinted tissue for tendon repairs with unprecedented patient benefits.
- HelexSOSV SOSV IndieBio NY 03
Genomic medicines for kidney diseases with high unmet need
- AuricleY Combinator W21
Neurostimulation implant to restore hearing & speech understanding
- Inso BioSOSV SOSV IndieBio NY 03
Next-generation sample prep. In Solution
- MelioSOSV SOSV IndieBio SF 13
Delivering pathogen testing at the speed of software with one test for all pathogens.
- Reach NeuroSOSV SOSV IndieBio SF 13
The first and only treatment option for chronic stroke patients to move again voluntarily
- Samphire NeuroscienceSOSV SOSV HAX 2021
Neurotechnology for Women's Health Needs